Keros Therapeutics, Inc. (KROS) — Shares Outstanding
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 19.54M | -51.8% |
| 2024 | 40.55M | +27.4% |
| 2023 | 31.84M | +15.6% |
| 2022 | 27.54M | +14.9% |
| 2021 | 23.97M | +3.4% |
| 2020 | 23.19M | +854.6% |
| 2019 | 2.43M | — |
| Fiscal Year | Shares Outstanding | Change YoY |
|---|---|---|
| 2025 | 19.54M | -51.8% |
| 2024 | 40.55M | +27.4% |
| 2023 | 31.84M | +15.6% |
| 2022 | 27.54M | +14.9% |
| 2021 | 23.97M | +3.4% |
| 2020 | 23.19M | +854.6% |
| 2019 | 2.43M | — |